scispace - formally typeset
J

Julen Oyarzabal

Researcher at University of Navarra

Publications -  123
Citations -  5155

Julen Oyarzabal is an academic researcher from University of Navarra. The author has contributed to research in topics: Epigenetics & Cancer. The author has an hindex of 33, co-authored 120 publications receiving 4154 citations. Previous affiliations of Julen Oyarzabal include University of California, San Francisco & University of Sheffield.

Papers
More filters
Journal ArticleDOI

A cell-based screen identifies ATR inhibitors with synthetic lethal properties for cancer-associated mutations

TL;DR: A cell-based screening strategy is described that has allowed us to identify compounds with ATR inhibitory activity in the nanomolar range that are being tested for cancer chemotherapy and are also very potent against ATM, ATR and the catalytic subunit of DNA-dependent protein kinase (DNA-PKcs).
Journal ArticleDOI

The CHEMDNER corpus of chemicals and drugs and its annotation principles.

Martin Krallinger, +52 more
TL;DR: The CHEMDNER corpus is presented, a collection of 10,000 PubMed abstracts that contain a total of 84,355 chemical entity mentions labeled manually by expert chemistry literature curators, following annotation guidelines specifically defined for this task.
Journal ArticleDOI

Phosphodiesterases as Therapeutic Targets for Alzheimer's Disease

TL;DR: The data supporting the use of PDE inhibitors as cognitive enhancers are summarized and the possible mechanisms of action underlying these effects are discussed.
Journal ArticleDOI

CHEMDNER: The drugs and chemical names extraction challenge

TL;DR: This task allowed a comparative assessment of the performance of various methodologies using a carefully prepared collection of manually labeled text prepared by specially trained chemists as Gold Standard data, and expected that the tools and resources resulting from this effort will have an impact in future developments of chemical text mining applications.